Skip to main content
. 2020 Mar 3;7:37. doi: 10.3389/fmolb.2020.00037

FIGURE 7.

FIGURE 7

MCC950 inhibits NLRP3 inflammasome activity and pro-inflammatory cytokine release. (A) We conducted a CoIP analysis to assess MCC950 (50 μM)-induced inhibition of NLPR3 inflammasome activation in OGD- or LPS-exposed spinal neurons. Left: WB analysis of NLRP3, ASC, and Caspase-1 (p20) levels in lysates/input. Right: We conducted CoIP analysis using an anti-NLRP3 antibody and subjected the CoIP products to WB analysis of NLRP3, ASC, and pro-Caspase-1 levels. (B) The levels of TNF-α, IL-1β, and IL-18 release. Data were reported as the mean ± SEM, n = 5. One-way ANOVA, *p < 0.05, ***p < 0.001, vs. control; #p < 0.05, ###p < 0.001, vs. OGD; &p < 0.05, &&&p < 0.001, vs. LPS. OGD, oxygen–glucose deprivation; LPS, lipopolysaccharides; CoIP, co-immunoprecipitation; WB, Western blot; SEM, standard error of the mean.